Susquehanna Portfolio Strategies’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$23.1M	Buy	+184,035	New	+$23.1M	0.51%	45
2024 Q3	–	Sell	-59,455	Closed	-$8.19M	–	448
2024 Q2	$8.19M	Sell	59,455 -55,244	-48%	-$7.61M	0.34%	81
2024 Q1	$15.8M	Hold	114,699	–	–	0.37%	76
2023 Q4	$15.1M	Buy	+114,699	New	+$15.1M	0.27%	109